Published 20 October 2021 Information about the Advanced Cancer Biology course VMFN29 (30 ECTS) can be found here The application period is from October 18th 2021 to January 17rd 2023 and you apply in the international admission portal The course period is from August 29th 2022 to January 23rd 2023.  

https://www.lucc.lu.se/article/international-admission-advanced-cancer-biology-course-open - 2025-02-05

Published 17 December 2021 After a major development work where researchers and experts in urology, communication and IT have collaborated, Region Skåne landed Organized prostate cancer testing, OPT, 2020. Photo: iStockphoto With 10,000 new cases a year, prostate cancer is the most common cancer type in Sweden. To create equal, accessible and high-quality prostate cancer care, Region Skåne has int

https://www.lucc.lu.se/article/organised-prostate-cancer-testing-provide-more-equal-care - 2025-02-05

Published 7 March 2022 Göran Jönsson, Professor in molecular oncology at Lund University. Photo: Tove Smeds Congratulations to Göran Jönsson who receives this year's Göran Gustafsson Prize in medicine. The prize is awarded by the Royal Academy of Sciences and is awarded to younger researchers who have achieved great success in their field. Göran Jönsson, professor in molecular oncology at Lund Uni

https://www.lucc.lu.se/article/goran-jonsson-receives-goran-gustafssons-prize-medicine-groundbreaking-research-immunotherapy-cancer - 2025-02-05

Published 18 March 2022 Alexander Pietras, Associate Professor at Lund University, have been awarded an European Research Council Consolidator Grant (ERC-CoG) for the project - RESISTANCEPROGRAMS. The research group will explore and exploite the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors. Glioblastoma multiforme (GBM), the deadliest form of bra

https://www.lucc.lu.se/article/euroupean-research-council-consolidator-grant-alexander-pietras - 2025-02-05

Published 12 April 2022 istock/selvanegra In a recent study from Lund University in Sweden, researchers discovered that metabolic changes affect how blood cells are formed during embryonic development. They found a previously unknown metabolic switch with a key role in how different types of blood cells develop. This means blood cell formation can be directed towards producing natural killer cells

https://www.lucc.lu.se/article/metabolism-found-regulate-production-killer-cells - 2025-02-05

Published 13 April 2022 iStock/Design cells In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionised areas of cancer care. However, there are still significant challenges in the identification of cancer cell surface proteins as ta

https://www.lucc.lu.se/article/new-precision-technology-immunotherapy - 2025-02-05

Published 11 May 2022 Smokers have a lower risk of developing prostate cancer, but a higher risk of dying from the disease, according to a large population study led by Lund University in Sweden. The researchers followed more than 350 000 people over several decades, and the results are now published in European Urology. It is well known that smokers have an increased risk of developing various ca

https://www.lucc.lu.se/article/smoking-worsens-prognosis-men-prostate-cancer - 2025-02-05

Published 15 May 2022 Skåne University Hospital Cancer Centre (SUHCC) has been accredited as Comprehensive Cancer Centre (CCC) by the Organisation of European Cancer Institutes (OECI). The accreditation as Comprehensive Cancer Centre means that an organisation has been approved according to the highly set quality criteria of the Organisation of European Cancer Institutes (OECI). Skåne University H

https://www.lucc.lu.se/article/skane-university-hospital-cancer-centre-accredited-comprehensive-cancer-centre - 2025-02-05

Published 15 June 2022 Paul Bourgine, Researcher and Wallenberg Fellow in Molecular Medicine. Photo: Kennet Ruona. By using cells isolated from cancer patients and mixing them with a new technology called “OssiGel”, it is possible to engineer human mini-bones. These miniaturized organs consist of mature bone and marrow tissue and can be used as model to study the disease mechanisms behind cancers

https://www.lucc.lu.se/article/miniature-bones-research-model-cancer - 2025-02-05

Published 25 August 2022 Photo: iStock/33karen33 The environment in which breast cancer arises –the interplay between the patient’s BMI, tumour size and cancer-specific proteins –is of importance for the prognosis. This is shown in a study from Lund University in Sweden. The knowledge could further enhance precision medicine in breast cancer. Major advances in diagnostics and treatment have improv

https://www.lucc.lu.se/article/tumour-environment-can-affect-breast-cancer-prognosis - 2025-02-05

Published 21 October 2022 Illustration of T cell attack on cancer cell. Illustration: iStock/luismmoling Göran Jönsson, professor of molecular oncology, receives SEK 31 million from the Knut and Alice Wallenberg Foundation to enhance the effect of immunotherapy in the treatment of cancer patients. About 30 per cent of patients with metastatic melanoma benefit from immunotherapy. At the same time,

https://www.lucc.lu.se/article/sek-31-million-enhance-effect-immunotherapy-treatment-cancer-patients - 2025-02-05

Published 15 November 2022 Photo: iStock/kan2d Researchers at Lund University in Sweden have identified one of the reasons why the childhood cancer neuroblastoma becomes resistant to chemotherapy. The findings are significant for how future treatments should be designed. The results have been published in Science Advances. Neuroblastoma is an aggressive cancer of the sympathetic nervous system, es

https://www.lucc.lu.se/article/altered-cell-behaviour-behind-resistance-neuroblastoma - 2025-02-05

Published 13 February 2023 Johan Flygare and Aurélie Baudet, stem cell researchers at Lund University. Photo: Johan Persson. Stem cells programmed to produce insulin in people with type 1 diabetes or to repair the heart muscle after a heart attack. Gene and cell therapies that improve cancer treatments. These new and innovative therapies have the potential to cure, alleviate and treat diseases whe

https://www.lucc.lu.se/article/advanced-treatments-future-are-soon-here - 2025-02-05

Published 13 February 2023 Dolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples of cellular programming sparked his curiosity about the human body. Photo: Johan Persson By reprogramming tumour cells to become the body’s defenders, Filipe Pereira and his colleagues hope to improve curren

https://www.lucc.lu.se/article/reprogramming-cancer-cells-immune-defenders - 2025-02-05

Published 14 February 2023 Paul Bourgine, Researcher and Wallenberg Fellow in Molecular Medicine. Photo: Kennet Ruona. Researchers at Lund University have generated human mini bones in the lab which mirror the composition and function of human bone. The results published in Science Translational Medicine detail this step toward the future development of patient-tailored, personalized models of bon

https://www.lucc.lu.se/article/toward-personalized-approach-study-and-treatment-bone-cancers - 2025-02-05

Published 19 May 2023 Congratulations to Jessica Wihl with the PhD thesis entitled "Multidisciplinary Team Meetings in Cancer Care: Case Discussions, Patient Selection, Leadership" who was awarded with the best cancer PhD thesis of year 2022. The award was presented 4 May 2023 at Lund University Cancer Centre internal one-day meeting with presentation of the thesis by the winner. The prize sum was

https://www.lucc.lu.se/article/best-phd-thesis-award-cancer-2022-lund-university - 2025-02-05

Published 21 May 2023 Christelle Prinz, Professor of Solid State Physics at Lund University, has been awarded an ERC Proof of Concept Grant for her research into creating cost-effective biosensor diagnostics for the early detection of ovarian cancer. What is your research project about? The project is a collaboration work with Dr. Jae Yen Shin, a former colleague and entrepreneur. We will use my l

https://www.lucc.lu.se/article/erc-grant-research-early-detection-ovarian-cancer - 2025-02-05

Published 25 June 2023 Håkan Axelson's research group is part of the large EU-funded KATY project, which focuses on the most common type of kidney cancer, clear cell renal cell carcinoma, which is one of the ten most common types of cancer worldwide. Image: iStock. What happens when you mix a group of tumor biology researchers with software developers and AI researchers? Hopefully, with the help o

https://www.lucc.lu.se/article/kicking-kidney-cancer - 2025-02-05

Published 2 October 2023 Kristina Lång (Photo: Erika Svantesson) Mammography screening supported by artificial intelligence (AI) is a safe alternative to today’s conventional double reading by radiologists and can reduce heavy workloads for doctors. This has now been shown in an interim analysis of a prospective, randomised controlled trial, which addressed the clinical safety of using AI in mammo

https://www.lucc.lu.se/article/ai-supported-mammography-screening-found-be-safe - 2025-02-05

Published 2 October 2023 Image: iStock/Rasi Bhadramani BRCA1 and BRCA2 are well-known breast cancer genes associated with a significantly increased risk of hereditary breast and ovarian cancer. However, there are an additional eleven genes associated with elevated risk for these types of cancer. A multi-year Swedish study now reveals that the proportion of women with genetically confirmed heredita

https://www.lucc.lu.se/article/breast-cancer-study-altered-guidelines-sweden - 2025-02-05